GREEN BAY, WI — David Novak, a patient at the Hemophilia Outreach Center, made history as the first Wisconsinite — and only the second person in the nation — to receive the newly FDA-approved gene therapy treatment ROCTAVIAN for hemophilia A. This breakthrough offers hope for reducing or eliminating the need for regular infusions and marks a major milestone for the hemophilia community.
How Hemophilia Shapes a Family, Part 2 with Christopher George and Felicity Grajeda
Today on Beyond the Bleeds, Heather and John are joined once again by Christopher George and his daughter, Felicity Grajeda, for part two of their conversation exploring how hemophilia shapes a family and the lessons, experiences, and support that can carry from one...

